Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.
Sovershaeva, E; KRANZER, K; Mchugh, G; Bandason, T; MAJONGA, ED; Usmani, OS; Rowland-Jones, S; Gutteberg, T; Flægstad, T; FERRAND, RA; Odland, JØ;
2019
AIDS, (2019).33 11 10.1097/QAD.0000000000002265.
An Auto-luminescent Fluorescent BCG Whole Blood Assay to Enable Evaluation of Paediatric Mycobacterial Responses Using Minimal Blood Volumes.
BASU ROY, R; Sambou, B; Uhía, I; ROETYNCK, S; Robertson, BD; KAMPMANN, B;
2019
Frontiers in Pediatrics, (2019).7 APR 10.3389/fped.2019.00151.
New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?.
KRANZER, K; Kalsdorf, B; Heyckendorf, J; Andres, S; Merker, M; Hofmann-Thiel, S; Bloemberg, GV; Hoffmann, H; Niemann, S; Lange, C; Maurer, FP;
2019
American journal of respiratory and critical care medicine, (2019).200 4 10.1164/rccm.201902-0260LE.
In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection.
Lee, H; Kim, J; Kang, YA; Kim, DR; Sim, B; ZELMER, A; FLETCHER, HA; DOCKRELL, HM; SMITH, SG; Cho, S-N;
2019
Frontiers in Immunology, (2019).10 APR 10.3389/fimmu.2019.00896.
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
Penn-Nicholson, A; Hraha, T; Thompson, EG; Sterling, D; Mbandi, SK; Wall, KM; Fisher, M; Suliman, S; Shankar, S; Hanekom, WA; Janjic, N; Hatherill, M; Kaufmann, SH E; SUTHERLAND, J; Walzl, G; De Groote, MA; Ochsner, U; Zak, DE; Scriba, TJ; ACS and GC6–74 cohort study groups,;
2019
PLoS medicine, (2019).16 4 10.1371/journal.pmed.1002781.
Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up.
Farr, K; Nalugwa, T; Ojok, C; Nantale, M; Nabwire, S; Oyuku, D; Shete, PB; Han, AH; FIELDING, K; Joloba, M; Mugabe, F; Dowdy, DW; MOORE, D; Davis, JL; Katamba, A; Cattamanchi, A;
2019
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, (2019).15, 10.1016/j.jctube.2019.100099.
Diabetes Mellitus Among Pulmonary Tuberculosis Patients From 4 Tuberculosis-endemic Countries: The TANDEM Study.
UGARTE-GIL, C; Alisjahbana, B; Ronacher, K; Riza, AL; Koesoemadinata, RC; Malherbe, ST; Cioboata, R; Llontop, JC; Kleynhans, L; Lopez, S; Santoso, P; Marius, C; Villaizan, K; Ruslami, R; Walzl, G; Panduru, NM; DOCKRELL, HM; Hill, PC; Mc Allister, S; Pearson, F; MOORE, DA J; Critchley, JA; Van Crevel, R;
2019
Clinical infectious diseases, (2019).70 5 10.1093/cid/ciz284.
Improving the quality of modelling evidence used for tuberculosis policy evaluation.
Menzies, NA; MCQUAID, CF; Gomez, GB; Siroka, A; Glaziou, P; Floyd, K; WHITE, RG; HOUBEN, RM G J;
2019
The international journal of tuberculosis and lung disease, (2019).23 4 10.5588/ijtld.18.0660.
Linezolid for drug-susceptible tuberculosis.
Ahmed, S; MOORE, DA; Nimmo, C; Nunn, AJ; Yates, TA; North London TB Journal Club,;
2019
LANCET INFECTIOUS DISEASES, (2019).19 4 10.1016/S1473-3099(19)30110-0.
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome.
Duffy, FJ; Weiner, J; Hansen, S; Tabb, DL; Suliman, S; Thompson, E; Maertzdorf, J; Shankar, S; Tromp, G; Parida, S; Dover, D; Axthelm, MK; SUTHERLAND, JS; DOCKRELL, HM; Ottenhoff, TH M; Scriba, TJ; Picker, LJ; Walzl, G; Kaufmann, SH E; Zak, DE; GC6-74 Consortium,;
2019
FRONTIERS IN IMMUNOLOGY, (2019).10 MAR 10.3389/fimmu.2019.00527.